Purple Biotech Ltd.PPBTNASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank91
5Y CAGR-4.0%
Year-over-Year Change
Year-over-year operating cash flow growth rate
5Y CAGR
-4.0%/yr
Long-term compound
Percentile
P91
Near historical high
vs 5Y Ago
0.8x
Contraction
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 27.89% |
| 2023 | -19.06% |
| 2022 | -11.04% |
| 2021 | -24.64% |
| 2020 | -116.66% |
| 2019 | 34.19% |
| 2018 | 1.70% |
| 2017 | -37.77% |
| 2016 | -89.30% |
| 2015 | 26.91% |